← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
University Of Kansas Medical
$0
Total funding
2
Grants
Funding over time
peak $0 · FY2005–06$1$1$1$0$0
'05
'06
Funding mix
By agency
NIH$0 · 2
By mechanism
N01$0 · 2
Investigators at University Of Kansas Medical
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
WSn76 A STUDY TO IDENTIFY BIOMARKER MODULATION BY CYCLOOXYGENASE-2 /CO-261015135$0
N01 · FY2004 · CN
WS#76 A STUDY TO IDENTIFY BIOMARKER MODULATION BY CYCLOOXYGENASE-2 /CO-261015135$0
N01 · FY2006 · CN
PHASE 1 MULTIPLE-DOSE SAFETY PHARMACOKINETIC AND DRUG INTERACTION CLIN-261035008$0
N01 · FY2006 · CN
PHASE 1 MULTIPLE-DOSE SAFETY. PHARMACOKINETIC. AND DRUG INTERACTION CL-261035008$0
N01 · FY2004 · CN
WS#76 A STUDY TO IDENTIFY BIOMARKER MODULATION BY CYCLOOXYGENASE-2 /CO-261015135$0
N01 · FY2005 · CN
PHASE 1 MULTIPLE-DOSE SAFETY PHARMACOKINETIC AND DRUG INTERACTION CLIN-261035008$0
N01 · FY2005 · CN